December 2, 2025/
This document is the October 2025 newsletter (Volume 19, Issue 10) from the Egyptian Pharmacovigilance Center (EPVC). It is a detailed bulletin focused on drug safety monitoring and public health...
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
This document is the October 2025 newsletter (Volume 19, Issue 10) from the Egyptian Pharmacovigilance Center (EPVC). It is a detailed bulletin focused on drug safety monitoring and public health...
This document is the official strategy published by the World Health Organization (WHO) to guide countries on how to harness the potential of traditional, complementary, and integrative medicine...
This document is the September 2025 newsletter (Volume 19, Issue 9) from the Egyptian Pharmacovigilance Center (EPVC).
